STING1 and neoplasm: Additionally, LNDs elicited long‐term immune memory, preventing tumor rechallenge, while exhibiting minimal systemic toxicity.[39] This strategy offers several advantages over conventional liposomal STING agonist delivery, including enhanced tumor penetration and an improved safety profile, ultimately maximizing therapeutic efficacy while minimizing off‐target toxicity.